What does increasing regulatory oversight mean for the pharma supply chain?
The Network Effect
AUGUST 26, 2014
Due to more complex supply chains, policy makers worldwide are enforcing stricter regulations for manufacturing and logistics. Within a decade, the number of FDA warning letters sent to medical device manufacturers has increased threefold, from 61 letters in 2002 to 181 in 2012 (EC A 2012). appeared first on The Network Effect.
74 
Let's personalize your content